SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IRENs quarterly results and earnings call are driving attention, with strong AI-cloud growth and a larger backlog countered by a delay in bringing contracted capacity online until January or February after a customer-requested redesign and supplier timing. Bulls point to demand and customer prepayments, while bears focus on execution, debt and remaining capital needs amid a sharp, volatile selloff and rebound in AI-related shares.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is caught in a broad AI and semiconductor selloff as election-related concerns about tighter data-center rules and slower infrastructure spending prompt investors to reassess the AI trade. Traders debate whether those fears are overblown and are buying the sharp dip, while others warn the downturn may continue and question whether any rebound will hold.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is caught in a broad semiconductor selloff as traders reassess whether political pushback and proposed restrictions on data-center construction could slow AI infrastructure spending. The community is split between fears of an AI-capex reset and dip buyers who argue demand remains strong and projects can move to other locations.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X ETF

A sharp selloff in semiconductor stocks has fueled a rally in the 3x inverse SOXS, amid trader concerns about AI spending and data-center policy; others are looking for a chip rebound and warning that the leveraged ETFs volatility can quickly reverse gains.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs quarterly earnings beat and higher full-year revenue outlook are drawing attention, but shares have sold off despite the upbeat results. Traders are weighing growth and backlog against cash burn, dilution, and whether reported growth reflects durable demand for IonQs core platform.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

A sharp selloff in Rigetti and other quantum-computing stocks has traders focused on the companys upcoming earnings and the sectors weak near-term fundamentals. Dip buyers expect a rebound and point to quantums long-term potential, while skeptics cite limited commercial revenue, cash burn, dilution risk, and high valuations.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is drawing attention after a sharp technology selloff, with traders linking the move to worries that post-election opposition or regulation could slow data-center construction and AI spending. The community is split between calling the rebound a temporary bounce and viewing the selloff as an opportunity, while debating whether the AI-growth outlook has materially changed.

VS Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

A sharp volatility spike amid a broad market selloff has driven UVIX higher, drawing attention to the ETFs leveraged exposure to VIX futures. Traders are split between expecting more market turmoil and taking profits or warning that volatility spikes can fade quickly and UVIXs decay can erode gains.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS) segments. The ATS segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The CCS segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica is drawing attention after strong quarterly results and an aggressive 2027 outlook failed to prevent a sharp selloff alongside AI and semiconductor stocks. Bulls see the decline as disconnected from demand for data-center hardware, while skeptics point to weaker cash-flow expectations, low margins, and customer concentration as risks to that growth story.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros post-Q3 selloff is drawing attention after a strong quarterly report was overshadowed by a softer full-year outlook and concerns about slowing same-store sales and customer traffic; analyst price-target cuts added to the pressure. Traders are divided between viewing the decline as an overreaction and buying opportunity and warning that slowing growth, competition, high valuation, and squeezed consumers could weigh further on the stock.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MERGER VOTE ALERT: The M&A Class Action Firm Is Investigating the Merger Vote -- UTZ, SAFT, PASG and FNWD

MERGER VOTE ALERT: The M&A Class Action Firm Is Investigating the Merger Vote -- UTZ, SAFT, PASG and FNWD MERGER VOTE ALERT: The M&A Class Action Firm Is Investigating the Merger Vote -- UTZ, SAFT, PASG and FNWDPR NewswireNEW YORK, Oct. 25, 2026 NEW YORK, Oct. 25, 2026 /PRNewswire/ -- Class Action...

EQUITY ALERT: The M&A Class Action Firm Is Investigating the Merger -- UTZ, SAFT, PASG and FNWD - IS IT A FAIR DEAL FOR YOU?

EQUITY ALERT: The M&A Class Action Firm Is Investigating the Merger -- UTZ, SAFT, PASG and FNWD - IS IT A FAIR DEAL FOR YOU? EQUITY ALERT: The M&A Class Action Firm Is Investigating the Merger -- UTZ, SAFT, PASG and FNWD - IS IT A FAIR DEAL FOR YOU?PR NewswireNEW YORK, Oct. 21, 2026 NEW YORK, Oct...

PASG Stock Alert: Halper Sadeh LLC is Investigating Whether Passage Bio, Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Passage Bio, Inc. (NASDAQ: PASG) and Remix Therapeutics, Inc. Upon closing of the proposed transaction, Passage Bio shareholders are expected to own approximately 7% of the combined company. Halper Sadeh encourages...

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRNX, SLP, NCSM, and PASG

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRNX, SLP, NCSM, and PASG $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRNX, SLP, NCSM, and PASG PR Newswire NEW YORK, July 23, 2026 NEW YORK, July 23, 2026 /PRNewswire...

SPRY, PASG, BOXL: Why These Stocks Plunged Double Digits In After-Hours Trading Today

Equity

The after-hours decline was driven by concerns over trading activity, business performance and company restructuring plans. 


PASG Stock Slumps 16% After-Hours — What’s Driving The Selloff?

Passage Bio said on Wednesday that it will merge with privately held Remix Therapeutics. 


Passage Bio Inc (PASG) Stock: Should You Buy the Dip For 125% Upside?

Passage Bio Inc (PASG) Stock: Should You Buy the Dip For 125% Upside...

This Mohawk Industries Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Tuesday

Wall Street analysts changed outlook for top names, including downgrading Mohawk Industries and Passage Bio. See analyst ratings for these stocks.read more...

Passage Bio (NASDAQ:PASG) CEO Sells $75,161.44 in Stock

Passage Bio, Inc. (NASDAQ:PASG - Get Free Report) CEO William Chou sold 4,076 shares of the business's stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of...

Insider Selling: Passage Bio (NASDAQ:PASG) CEO Sells $75,161.44 in Stock

Passage Bio, Inc. (NASDAQ:PASG - Get Free Report) CEO William Chou sold 4,076 shares of the firm's stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of...

Passage Bio, Inc. operates as a genetic medicines company. It focuses on development of therapies for central nervous system disorders. The company was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.

Passage Bio Inc

Neutral Sentiment

<ul class="summary-bullets"><li>ARS Pharmaceuticals shares tumbled after the company said Neffy failed to secure expanded commercial insurance coverage for the July 1 review cycle.&nbsp;</li><li>Passage Bio shares fell after the company agreed to merge with Remix Therapeutics in an all-stock deal.</li><li>Boxlight shares dropped after hours following a speculative rally fueled by the company's recent 1-for-6 reverse stock split.&nbsp;</li></ul>ARS Pharmaceuticals (SPRY), Passage Bio (PASG), and Boxlight Corp. (BOXL),&nbsp;all small-cap stocks, posted double-digit losses in after-hours trading on Wednesday as investors digested new business developments.<h2 class="st-heading-2">SPRY Faces Coverage Setback</h2>ARS Pharmaceuticals shares came under heavy selling after investors reacted to an <a href="https://stocktwits.com/news-articles/markets/equity/spry-stock-tanks-after-hours-ars-pharmaceuticals-reports-no-new-major-insurance-wins-for-neffy/cZK6ySGR7Q4">update</a> on insurance coverage for Neffy, the company's needle-free treatment for severe allergic reactions.&nbsp;The stock fell after the company said talks with health insurers did not lead to broader coverage for the July 1 review cycle. Investors saw the setback as a challenge to sales growth and increased product use.&nbsp;Commercial insurance support often plays a major role in determining how quickly newly approved therapies gain traction. Additionally, the company lowered its projected 2026 cash-based operating expense forecast to approximately $248 million.&nbsp;<a href="https://stocktwits.com/symbol/SPRY">ARS Pharmaceuticals’ stock</a> traded over 24% lower overnight. On Stocktwits, retail sentiment around the stock&nbsp;improved to ‘neutral’ from ‘bearish’ the previous day.&nbsp;<h2 class="st-heading-2">PASG Drops Following Deal Announcement</h2>Passage Bio declined after unveiling a <a href="https://stocktwits.com/news-articles/markets/equity/pasg-stock-slumps-after-hours-whats-driving-the-selloff/cZKyoZ4R7Q5">merger</a> agreement involving Remix Therapeutics, Inc. The companies have agreed to combine through an all-stock transaction that will create a publicly traded biotechnology company focused on RNA-processing therapies.&nbsp;The merged business plans to operate as Remix Therapeutics and list its shares on Nasdaq under the ticker symbol RMTX following the completion of the deal with existing Passage Bio shareholders expected to own roughly 7% of the combined entity.&nbsp;The transaction is accompanied by an oversubscribed private financing expected to generate approximately $100 million in gross proceeds from a group of investors led by Decheng Capital.<a href="https://stocktwits.com/symbol/PASG">Passage Bio stock</a> traded over 15% lower overnight. Retail sentiment around the stock improved to ‘extremely bullish’ from ‘bullish’ territory the previous day.&nbsp;<h2 class="st-heading-2">Post-Split Volatility Drives Sharp Reversal In BOXL After Massive Rally&nbsp;</h2>Boxlight shares pulled back in after-hours trading after jumping 37% during the regular session. The education technology company, which recently&nbsp;completed a reverse stock split to remain listed on Nasdaq, saw investors take profits after a surge driven by heavy speculative buying.&nbsp;The decline followed a daytime surge that pushed shares significantly higher before momentum faded. Traders appeared to reassess positions after a rapid advance fueled by heavy volume and a reduced share count.On Monday, Boxlight implemented a 1-for-6 reverse stock split, which reduced the number of authorized Class A shares, creating a much tighter trading float and increasing the stock’s sensitivity to buying and selling activity.<a href="https://stocktwits.com/symbol/BOXL">Boxlight stock</a> traded over 17% lower overnight. Retail sentiment around the stock jumped to ‘extremely bullish’ from ‘neutral’ territory the previous day.&nbsp;So far this year, PASG and BOXL stocks have plunged 50% and 52%, respectively, while SPRY stock has declined 9%.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/pfe-stock-continues-to-drop-as-lung-cancer-trial-disappointment-overshadows-ibrance-win/cZKyn58R7Qc">PFE Stock Continues To Drop As Lung Cancer Trial Disappointment Overshadows Ibrance Win</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

ProKidney (PROK) is developing rilparencel, an autologous cellular therapy aimed at slowing kidney function decline in patients with chronic kidney disease/ Photo credit: Getty Images

ARS Pharmaceuticals (SPRY), Passage Bio (PASG), and Boxlight Corp. (BOXL),&nbsp;all small-cap stocks, posted double-digit losses in after-hours trading on Wednesday as investors digested new business developments.

Boxlight Corp

ARS Pharmaceuticals Inc

Fundamental investor

Technical trader

A mix of both

Fundamental analysis looks at earnings, valuation, and business quality, while technical analysis focuses on chart patterns, price action, and indicators, and many investors blend the two. How do you decide what to buy: fundamentals or technicals? Vote and explain your reasoning in the comments.

Feed

News

Sentiment

Earnings

Fundamentals

Info

PASG Passage Bio Inc

Fundamentals

Latest PASG News